Literature DB >> 1281215

Soluble CD14 participates in the response of cells to lipopolysaccharide.

E A Frey1, D S Miller, T G Jahr, A Sundan, V Bazil, T Espevik, B B Finlay, S D Wright.   

Abstract

CD14 is a 55-kD protein found both as a glycosylphosphatidyl inositol-linked protein on the surface of mononuclear phagocytes and as a soluble protein in the blood. CD14 on the cell membrane (mCD14) has been shown to serve as a receptor for complexes of lipopolysaccharide (LPS) with LPS binding protein, but a function for soluble CD14 (sCD14) has not been described. Here we show that sCD14 enables responses to LPS by cells that do not express CD14. We have examined induction of endothelial-leukocyte adhesion molecule 1 expression by human umbilical vein endothelial cells, interleukin 6 secretion by U373 astrocytoma cells, and cytotoxicity of bovine endothelial cells. None of these cell types express mCD14, yet all respond to LPS in a serum-dependent fashion, and all responses are completely blocked by anti-CD14 antibodies. Immunodepletion of sCD14 from serum prevents responses to LPS, and the responses are restored by addition of sCD14. These studies suggest that a surface anchor is not needed for the function of CD14 and further imply that sCD14 must bind to additional proteins on the cell surface to associate with the cell and transduce a signal. They also indicate that sCD14 may have an important role in potentiating responses to LPS in cells lacking mCD14.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281215      PMCID: PMC2119444          DOI: 10.1084/jem.176.6.1665

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  CD14 and immune response to lipopolysaccharide.

Authors:  C R Maliszewski
Journal:  Science       Date:  1991-05-31       Impact factor: 47.728

2.  CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells.

Authors:  H Beekhuizen; I Blokland; A J Corsèl-van Tilburg; F Koning; R van Furth
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

3.  Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes.

Authors:  V Bazil; J L Strominger
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

4.  Monocyte antigen CD14 is a phospholipid anchored membrane protein.

Authors:  D L Simmons; S Tan; D G Tenen; A Nicholson-Weller; B Seed
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

5.  Structure and function of lipopolysaccharide binding protein.

Authors:  R R Schumann; S R Leong; G W Flaggs; P W Gray; S D Wright; J C Mathison; P S Tobias; R J Ulevitch
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

6.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

8.  A blocking monoclonal antibody to endothelial-leukocyte adhesion molecule-1 (ELAM1).

Authors:  C Benjamin; I Dougas; G Chi-Rosso; S Luhowskyj; M Rosa; B Newman; L Osborn; C Vassallo; C Hession; S Goelz
Journal:  Biochem Biophys Res Commun       Date:  1990-08-31       Impact factor: 3.575

9.  Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serum-dependent cytotoxic pathway.

Authors:  D Patrick; J Betts; E A Frey; R Prameya; K Dorovini-Zis; B B Finlay
Journal:  J Infect Dis       Date:  1992-05       Impact factor: 5.226

10.  Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14.

Authors:  S D Wright; R A Ramos; A Hermanowski-Vosatka; P Rockwell; P A Detmers
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  153 in total

1.  E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide.

Authors:  T Kawata; J R Bristol; D P Rossignol; J R Rose; S Kobayashi; H Yokohama; A Ishibashi; W J Christ; K Katayama; I Yamatsu; Y Kishi
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Synthesis and surface expression of CD14 by human endothelial cells.

Authors:  H P Jersmann; C S Hii; G L Hodge; A Ferrante
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation.

Authors:  D Filipp; K Alizadeh-Khiavi; C Richardson; A Palma; N Paredes; O Takeuchi; S Akira; M Julius
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

Review 4.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

5.  The lipopolysaccharide co-receptor CD14 is present and functional in seminal plasma and expressed on spermatozoa.

Authors:  C L Harris; M A Vigar; J E Rey Nores; V Horejsi; M O Labeta; B P Morgan
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

Review 6.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

7.  Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population.

Authors:  Hiroyoshi Doi; Tara K Iyer; Erica Carpenter; Hong Li; Kyong-Mi Chang; Robert H Vonderheide; David E Kaplan
Journal:  Hepatology       Date:  2012-01-19       Impact factor: 17.425

Review 8.  Markers of bacterial translocation in end-stage liver disease.

Authors:  Ioannis Koutsounas; Garyfallia Kaltsa; Spyros I Siakavellas; Giorgos Bamias
Journal:  World J Hepatol       Date:  2015-09-18

9.  Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14.

Authors:  M Arditi; J Zhou; R Dorio; G W Rong; S M Goyert; K S Kim
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.

Authors:  J Pugin; C C Schürer-Maly; D Leturcq; A Moriarty; R J Ulevitch; P S Tobias
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.